MIROCALS: Modifying Immune Response and OutComes in ALS

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: Riluzole;   Drug: IL-2;   Drug: 5% glucose water solution
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified February 2017